CSIMarket
 


Rebus Holdings Inc   (NSPX)
Other Ticker:  
 

Cumulative Rebus Holdings Inc 's Working Capital Ratio for Trailing Twelve Months Period

NSPX's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

NSPX Working Capital Ratio for Trailing Twelve Months Period

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Growth -8.75 % 6.49 % -6.84 % -9.56 % -52.92 %
Y / Y Current Assets Growth -96.6 % -99.15 % -99.3 % -86.53 % -76.55 %
Working Capital Ratio for Trailing Twelve Months Period 0.01 0.02 0.04 0.07 0.11
Total Ranking # 4263 # 4423 # 4982 # 4733 # 5593
Seq. Current Liabilities Growth -0.76 % 8.01 % -8.21 % -7.26 % 15.82 %
Seq. Current Assets Growth 80 % 0 % -96.27 % -49.43 % -55.01 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Despite year on year decrease in Rebus Holdings Inc 's average Current Liabilities to $6 millions, Working Capital Ratio for Trailing Twelve Months Period to 0.01 below company average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 531 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Rebus Holdings Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about NSPX
Working Capital Ratio NSPX in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 532
Sector # 1099
S&P 500 # 4264


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.11 0.04 0
(Mar 31 2022)   (Jun 30 2018)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Rebus Holdings Inc   0.02 
Theralink Technologies Inc   0.02 
Adhera Therapeutics Inc   0.02 
Q Biomed inc   0.01 
Propanc Biopharma Inc   0.01 
Nanomix Corp  0.01 
Kaya Holdings Inc  0.01 
Respirerx Pharmaceuticals Inc   0.01 
Cannapharmarx Inc 0.00 
Globestar Therapeutics Corporation 0.00 
Hst Global Inc 0.00 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com